Clinical Endocrinology, volume 102, issue 5, pages 557-558

In Reply to Gad Et Al “Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay”

Robert D Nerenz ¹

Bradley R Javorsky ^{2, 3}

Jenna Sarvaideo ^{2, 3}

Joely A Straseski ⁴

Erin Earll ⁵

Department of Pathology and Laboratory Medicine Medical College of Wisconsin Milwaukee Wisconsin USA |

Department of Medicine Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin Milwaukee Wisconsin USA |

Clement J. Zablocki VA Medical Center Milwaukee Wisconsin USA

⁴

Department of Pathology University of Utah Health Sciences Center Salt Lake City Utah USA |

⁵

Medical College of Wisconsin Milwaukee Wisconsin USA |

Publication type: Journal Article

Publication date: 2025-01-08

Wiley

Journal: Clinical Endocrinology

scimago Q2

SJR: 0.978

CiteScore: 6.4

Impact factor: 3

ISSN: 03000664, 13652265

DOI: 10.1111/cen.15191

Copy DOI

Found

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex | MLA

Found error?

Publisher

Wiley

Journal

scimago Q2

SJR

0.978

CiteScore

6.4

Impact factor

ISSN

03000664 (Print)

13652265 (Electronic)